Which has preferable valuation & earnings, SYNT or VCT?

Victrex has lower revenue, but higher earnings than Synthomer. Victrex is trading at a lower price-to-earnings ratio than Synthomer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.74B 0.08 -£82.04M -£96.00 N/A Victrex £296.40M 1.71 £30.80M -£22.40 N/A

Is SYNT or VCT more profitable?

Victrex has a net margin of -6.70% compared to Synthomer's net margin of -9.03%. Victrex's return on equity of -4.95% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -9.03% -16.66% -0.28% Victrex -6.70% -4.95% 6.59%

Do analysts prefer SCPA or SYNT?

Synthomer has a consensus price target of GBX 86.75, suggesting a potential upside of 2.42%. Given Synthomer's stronger consensus rating and higher probable upside, analysts plainly believe Synthomer is more favorable than Scapa Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Scapa Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Synthomer 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better valuation and earnings, ESNT or SYNT?

Essentra has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Essentra £302M 0.78 £3.50M £0.70 119.57 Synthomer £1.74B 0.08 -£82.04M -£96.00 N/A

Is ESNT or SYNT more profitable?

Essentra has a net margin of 0.70% compared to Synthomer's net margin of -9.03%. Essentra's return on equity of 0.79% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Essentra 0.70% 0.79% 1.74% Synthomer -9.03% -16.66% -0.28%

Which has preferable earnings and valuation, SYNT or ZTF?

Zotefoams has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.74B 0.08 -£82.04M -£96.00 N/A Zotefoams £158.49M 1.39 £9.80M £44.87 10.02

Is SYNT or ZTF more profitable?

Zotefoams has a net margin of 14.28% compared to Synthomer's net margin of -9.03%. Zotefoams' return on equity of 18.25% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -9.03% -16.66% -0.28% Zotefoams 14.28% 18.25% 5.48%

Which has stronger valuation & earnings, SYNT or TET?

Treatt has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.74B 0.08 -£82.04M -£96.00 N/A Treatt £128.29M 1.40 £11.22M £7.22 42.24

Is SYNT or TET more profitable?

Treatt has a net margin of 3.40% compared to Synthomer's net margin of -9.03%. Treatt's return on equity of 3.22% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -9.03% -16.66% -0.28% Treatt 3.40% 3.22% 6.72%

Synthomer (SYNT) Competitors

GBX 84.70 -3.30 (-3.75%)

As of 07/6/2026 11:56 AM Eastern

Compare

SYNT vs. VCT, SCPA, ESNT, ZTF, and TET

Should you buy Synthomer stock or one of its competitors? MarketBeat compares Synthomer with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Synthomer include Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Zotefoams (ZTF), and Treatt (TET). These companies are all part of the "specialty chemicals" industry.

How does Synthomer compare to Victrex?

Synthomer (LON:SYNT) and Victrex (LON:VCT) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

Victrex has lower revenue, but higher earnings than Synthomer. Victrex is trading at a lower price-to-earnings ratio than Synthomer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.74B	0.08	-£82.04M	-£96.00	N/A
Victrex	£296.40M	1.71	£30.80M	-£22.40	N/A

Victrex has a net margin of -6.70% compared to Synthomer's net margin of -9.03%. Victrex's return on equity of -4.95% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-9.03%	-16.66%	-0.28%
Victrex	-6.70%	-4.95%	6.59%

19.7% of Synthomer shares are held by institutional investors. Comparatively, 75.5% of Victrex shares are held by institutional investors. 5.0% of Synthomer shares are held by company insiders. Comparatively, 4.2% of Victrex shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Synthomer has a beta of 1.02, suggesting that its share price is 2% more volatile than the broader market. Comparatively, Victrex has a beta of 0.756, suggesting that its share price is 24% less volatile than the broader market.

In the previous week, Victrex had 2 more articles in the media than Synthomer. MarketBeat recorded 2 mentions for Victrex and 0 mentions for Synthomer. Victrex's average media sentiment score of 0.47 beat Synthomer's score of 0.00 indicating that Victrex is being referred to more favorably in the news media.

Company	Overall Sentiment
Synthomer	Neutral
Victrex	Neutral

Synthomer currently has a consensus price target of GBX 86.75, suggesting a potential upside of 2.42%. Victrex has a consensus price target of GBX 662.86, suggesting a potential upside of 13.89%. Given Victrex's stronger consensus rating and higher probable upside, analysts clearly believe Victrex is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Victrex	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

Summary

Victrex beats Synthomer on 12 of the 16 factors compared between the two stocks.

How does Synthomer compare to Scapa Group?

Scapa Group (LON:SCPA) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

19.7% of Synthomer shares are held by institutional investors. 5.0% of Synthomer shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Scapa Group has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Scapa Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scapa Group	£281.80M	0.00	N/A	-£29.30	N/A
Synthomer	£1.74B	0.08	-£82.04M	-£96.00	N/A

Synthomer has a consensus price target of GBX 86.75, suggesting a potential upside of 2.42%. Given Synthomer's stronger consensus rating and higher probable upside, analysts plainly believe Synthomer is more favorable than Scapa Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scapa Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Scapa Group has a net margin of 0.00% compared to Synthomer's net margin of -9.03%. Scapa Group's return on equity of 0.00% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Scapa Group	N/A	N/A	N/A
Synthomer	-9.03%	-16.66%	-0.28%

In the previous week, Scapa Group's average media sentiment score of 0.00 equaled Synthomer'saverage media sentiment score.

Company	Overall Sentiment
Scapa Group	Neutral
Synthomer	Neutral

Summary

Synthomer beats Scapa Group on 6 of the 10 factors compared between the two stocks.

How does Synthomer compare to Essentra?

Essentra (LON:ESNT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

69.5% of Essentra shares are held by institutional investors. Comparatively, 19.7% of Synthomer shares are held by institutional investors. 0.5% of Essentra shares are held by insiders. Comparatively, 5.0% of Synthomer shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Essentra has a net margin of 0.70% compared to Synthomer's net margin of -9.03%. Essentra's return on equity of 0.79% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Essentra	0.70%	0.79%	1.74%
Synthomer	-9.03%	-16.66%	-0.28%

In the previous week, Essentra had 1 more articles in the media than Synthomer. MarketBeat recorded 1 mentions for Essentra and 0 mentions for Synthomer. Essentra's average media sentiment score of 0.59 beat Synthomer's score of 0.00 indicating that Essentra is being referred to more favorably in the media.

Company	Overall Sentiment
Essentra	Positive
Synthomer	Neutral

Essentra has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Essentra	£302M	0.78	£3.50M	£0.70	119.57
Synthomer	£1.74B	0.08	-£82.04M	-£96.00	N/A

Essentra has a beta of 0.829, meaning that its stock price is 17% less volatile than the broader market. Comparatively, Synthomer has a beta of 1.02, meaning that its stock price is 2% more volatile than the broader market.

Essentra currently has a consensus price target of GBX 150, suggesting a potential upside of 79.21%. Synthomer has a consensus price target of GBX 86.75, suggesting a potential upside of 2.42%. Given Essentra's stronger consensus rating and higher possible upside, equities analysts clearly believe Essentra is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Essentra	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Essentra beats Synthomer on 13 of the 16 factors compared between the two stocks.

How does Synthomer compare to Zotefoams?

Synthomer (LON:SYNT) and Zotefoams (LON:ZTF) are both small-cap basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation.

Synthomer has a beta of 1.02, meaning that its share price is 2% more volatile than the broader market. Comparatively, Zotefoams has a beta of 1.239, meaning that its share price is 24% more volatile than the broader market.

In the previous week, Zotefoams had 1 more articles in the media than Synthomer. MarketBeat recorded 1 mentions for Zotefoams and 0 mentions for Synthomer. Zotefoams' average media sentiment score of 0.84 beat Synthomer's score of 0.00 indicating that Zotefoams is being referred to more favorably in the news media.

Company	Overall Sentiment
Synthomer	Neutral
Zotefoams	Positive

19.7% of Synthomer shares are held by institutional investors. Comparatively, 29.6% of Zotefoams shares are held by institutional investors. 5.0% of Synthomer shares are held by insiders. Comparatively, 4.5% of Zotefoams shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Synthomer currently has a consensus target price of GBX 86.75, indicating a potential upside of 2.42%. Zotefoams has a consensus target price of GBX 605, indicating a potential upside of 34.59%. Given Zotefoams' stronger consensus rating and higher probable upside, analysts clearly believe Zotefoams is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Zotefoams has a net margin of 14.28% compared to Synthomer's net margin of -9.03%. Zotefoams' return on equity of 18.25% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-9.03%	-16.66%	-0.28%
Zotefoams	14.28%	18.25%	5.48%

Zotefoams has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.74B	0.08	-£82.04M	-£96.00	N/A
Zotefoams	£158.49M	1.39	£9.80M	£44.87	10.02

Summary

Zotefoams beats Synthomer on 14 of the 16 factors compared between the two stocks.

How does Synthomer compare to Treatt?

Synthomer (LON:SYNT) and Treatt (LON:TET) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.

Synthomer currently has a consensus target price of GBX 86.75, indicating a potential upside of 2.42%. Treatt has a consensus target price of GBX 248.33, indicating a potential downside of 18.58%. Given Synthomer's higher possible upside, analysts clearly believe Synthomer is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Treatt has a net margin of 3.40% compared to Synthomer's net margin of -9.03%. Treatt's return on equity of 3.22% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-9.03%	-16.66%	-0.28%
Treatt	3.40%	3.22%	6.72%

19.7% of Synthomer shares are owned by institutional investors. Comparatively, 17.5% of Treatt shares are owned by institutional investors. 5.0% of Synthomer shares are owned by company insiders. Comparatively, 4.1% of Treatt shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Synthomer has a beta of 1.02, meaning that its stock price is 2% more volatile than the broader market. Comparatively, Treatt has a beta of 0.907, meaning that its stock price is 9% less volatile than the broader market.

Treatt has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.74B	0.08	-£82.04M	-£96.00	N/A
Treatt	£128.29M	1.40	£11.22M	£7.22	42.24

In the previous week, Synthomer's average media sentiment score of 0.00 equaled Treatt'saverage media sentiment score.

Company	Overall Sentiment
Synthomer	Neutral
Treatt	Neutral

Summary

Treatt beats Synthomer on 9 of the 14 factors compared between the two stocks.

Get Synthomer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SYNT vs. The Competition

Export

Metric	Synthomer	Specialty Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£138.86M	£8.77B	£4.65B	£2.83B
Dividend Yield	28.47%	3.41%	5.02%	6.15%
P/E Ratio	-0.88	15.06	21.39	369.52
Price / Sales	0.08	115.57	6,499.64	86,119.00
Price / Cash	2.28	19.56	24.20	27.87
Price / Book	0.13	3.42	8.82	7.84
Net Income	-£82.04M	£213.62M	£157.26M	£5.89B
7 Day Performance	6.14%	0.77%	1.75%	0.86%
1 Month Performance	-17.93%	-1.01%	-1.90%	-0.47%
1 Year Performance	-9.61%	22.99%	46.22%	70.60%

Synthomer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SYNT Synthomer	1.4072 of 5 stars	GBX 84.70 -3.8%	GBX 86.75 +2.4%	-9.8%	£138.86M	£1.74B	N/A	4,200
VCT Victrex	2.105 of 5 stars	GBX 602.21 +0.5%	GBX 662.86 +10.1%	-25.5%	£524.67M	£296.40M	N/A	1,109
SCPA Scapa Group	N/A	N/A	N/A	N/A	£402.98M	£281.80M	N/A	1,461
ESNT Essentra	3.8245 of 5 stars	GBX 81.80 -0.7%	GBX 150 +83.4%	-27.2%	£229.21M	£302M	116.86	350	High Trading Volume
ZTF Zotefoams	4.6969 of 5 stars	GBX 430 +1.5%	GBX 605 +40.7%	+39.6%	£211.48M	£158.49M	9.58	549	Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:SYNT) was last updated on 7/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synthomer (SYNT) Competitors